A Randomized Phase 3 Study of MRTX849 in Combination with Cetuximab Versus Chemotherapy in Patients with Advanced Colorectal Cancer with KRAS G12C Mutation with Disease Progression On or After Standard First-Line Therapy (NCT04793958)
KRYSTAL-10
This trial is No longer recruiting
Registration number NCT04793958
Program & service
This trial is being run with the Cancer service, and as part of the Medical Oncology program.
Trial phase
Phase 3
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Dr Sanjeev Gill
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR